Anthropic buys one-person drug startup that reached mouse trials in 18 months with Claude
APPSO · wechat · 2026-11-02
Anthropic disclosed it acquired Mithril Medicine in July — a pharma company whose only full-time employee is founder Cody Tranbarger. Working with 11 external labs and Claude as coordinator, he pushed two rare muscular dystrophy programs (LAMA2-CMD, alpha-dystroglycanopathy) to initial mouse trials in under 18 months, with some mice showing improved grip strength.
Model: humans judge, Claude plans and coordinates, external labs execute — a "Pipeline-in-a-Person." Claude digested 113 antibodies across 341 pages of production reports in under 8 minutes and revised experiment plans in 4; idea-to-research-design shrank from 1-2 months to 2-3 days. But errors propagate fast too: at least 3 of 6 Claude errors reached emails sent to labs.
Context: follows Anthropic's acquisitions of Coefficient Bio ($400M) and Bun; VC-backed AI acquisitions hit 195 deals in the first nine months of 2026, 14% above all of 2025. Candidate drugs are targeted for 2027, human trials potentially by late 2028.
More from Companies & People
- "There's nothing for you to do": Slack users auto-migrated to paid Salesforce support plan — Ben_Reinhardt · 2026-11-04
- Meta's earnings call: Muse hit 10M+ setups in ~6 weeks, ~$200 average purchase — SuB8u · 2026-11-04
- Sakana AI demos Marlin, Fugu and Namazu agents at Gartner IT Symposium — SakanaAILabs · 2026-11-04
- Ex-X engineer explains mystery muted notifications: country flag bug — yacineMTB · 2026-11-04
- Researcher accuses Anthropic of lifting his 10-month zero-knowledge proof work — sull · 2026-11-04
- Tons of Anthropic employees are quitting — automated out of a job and free to found startups — bindureddy · 2026-11-04